LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | HG-5-88-01 | 10 | uM | LJP6 | 72 | hr | 929 | 2412 | 3216 | 0.7501 | 0.7035 |
Hs 578T | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 929 | 3750 | 3216 | 1.1660 | 1.1789 |
Hs 578T | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 929 | 3479 | 3216 | 1.0818 | 1.0895 |
Hs 578T | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2783 | 3216 | 0.8654 | 0.8449 |
Hs 578T | HG-6-64-01 | 1.11 | uM | LJP6 | 72 | hr | 929 | 1887 | 3216 | 0.5866 | 0.4848 |
Hs 578T | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1438 | 3216 | 0.4473 | 0.2760 |
Hs 578T | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 929 | 682 | 3216 | 0.2120 | -0.1590 |
Hs 578T | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 2920 | 3237 | 0.9022 | 0.8889 |
Hs 578T | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 929 | 2706 | 3237 | 0.8361 | 0.8106 |
Hs 578T | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 2418 | 3237 | 0.7470 | 0.7008 |
Hs 578T | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 929 | 1952 | 3237 | 0.6032 | 0.5104 |
Hs 578T | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1619 | 3237 | 0.5004 | 0.3616 |
Hs 578T | Neratinib | 10 | uM | LJP5 | 72 | hr | 929 | 933 | 3237 | 0.2884 | 0.0024 |
Hs 578T | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 929 | 3051 | 3216 | 0.9484 | 0.9415 |
Hs 578T | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 929 | 2955 | 3216 | 0.9188 | 0.9077 |
Hs 578T | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2608 | 3216 | 0.8111 | 0.7794 |
Hs 578T | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 929 | 2187 | 3216 | 0.6800 | 0.6126 |
Hs 578T | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1750 | 3216 | 0.5441 | 0.4239 |
Hs 578T | JW-7-24-1 | 10 | uM | LJP6 | 72 | hr | 929 | 864 | 3216 | 0.2685 | -0.0419 |
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 2282 | 3237 | 0.7051 | 0.6472 |
Hs 578T | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 929 | 1528 | 3216 | 0.4751 | 0.3198 |
Hs 578T | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 929 | 1756 | 3237 | 0.5425 | 0.4240 |
Hs 578T | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 929 | 1205 | 3216 | 0.3746 | 0.1556 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 1350 | 3237 | 0.4170 | 0.2297 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 929 | 1174 | 3216 | 0.3651 | 0.1393 |